Senior/Staff Software Engineer, Tech Lead
Merge Labs11 hours ago
Base Salary
$225k - $305k/yr
Responsibilities
- Own important software through problem definition, implementation, deployment, and continued operation.
- Translate experimental needs into achievable software milestones with clear acceptance criteria.
- Build and improve interfaces between applications, instrument SDKs, data systems, and infrastructure.
- Solve integration, concurrency, performance, and recovery problems with SDK and application engineers.
- Make decisions about languages, architecture, reuse, and build-versus-buy tradeoffs.
- Establish testing, observability, and release practices that improve reliability and research velocity.
- Build workflows for recording, storing, managing metadata for, and analyzing high-volume experimental data.
- Review code, mentor peers, communicate technical tradeoffs, and help prioritize work with the team manager.
Requirements
- Demonstrated delivery and post-release support of substantial software systems.
- Strong coding, debugging, and software fundamentals with the ability to learn unfamiliar technologies.
- Experience making architecture decisions across multiple components and explaining simplifications and tradeoffs.
- Good judgment regarding reliability, data integrity, performance, and operational failure modes.
- Evidence of helping other engineers deliver through code review, mentoring, and collaboration.
- Helpful but not required: experience with scientific software, robotics, instrumentation, imaging, lab automation, physical systems, Python, C++, Rust, Matlab, scientific data pipelines, high-throughput systems, or desktop applications.
- Previous people management experience or interest in developing people-management skills is helpful but not required.
Categories
About Merge Labs
Merge Labs is a privately held research lab developing high-bandwidth brain-computer interfaces that integrate with advanced AI to augment human capability. It builds experimental platforms and automated pipelines across molecular engineering, synthetic biology, neuroscience, advanced microscopy, sequencing, and mammalian cell culture to accelerate BCI R&D. Founded in 2025, the company focuses on safe, accessible neurotechnology rather than commercial products today.